INS and Insulin resistance: In severely obese patients, induced weight loss due to biliopancreatic diversion with duodenal switch also decreases circulating nesfatin-1 levels, which correlate with parameters of metabolic health after 12 months of the intervention, including improvements in weight, fat mass, fasting insulin levels and insulin resistance, cholesterol levels, and CRP circulating levels [232].